The diagnosis, treatment and follow-up of gastrointestinal stromal tumor in an adolescent patient
17 January 2024, 5:30 PM – 6:30 PM (CET)
Speaker: Marta Andrzejewska (Poland)
Expert: Monika Sparber-Sauer (Germany)
ALK-positive histiocytosis, a recently described rare subtype of histiocytosis
14 February 2024, 5:30 PM – 6:30 PM (CET)
Speaker: Delfien Bogaert (Belgium)
Expert: Milen Minkov (Austria)
An HR Acute Myeloid Leukemia case with persistent molecular MRD and repeated Sars-Cov2 infections
13 March 2024, 5:30 PM – 6:30 PM (CET)
Speaker: Guiseppina Aloj (Italy)
Expert: Carmelo Rizzari (Italy)
An infant SHH medulloblastoma with MYCN amplification showing early and aggressive relapse despite high intensity treatment
29 May 2024, 5:30 PM – 6:30 PM (CET)
Speaker: Beatriz Cófreces Pérez (UK)
Expert: Simon Bailey (UK)
Lessons Learned from Managing Ewing Sarcoma in a patient with severe pre-existing renal impairment
September 18, 2024, 5:30 PM – 6:30 PM (CET)
Speaker: Katherine Crombie (UK)
Expert: Bernadette Brennan (UK)
A challenging case of generalized precursor B-cell lymphoblastic lymphoma (pre-B-LBL) in an infant
16 October 2024, 5:30 PM – 6:30 PM (CET)
Speaker: Triin Pohlak (Estonia)
Expert: Birgit Burkhardt (Germany)
Excessive treatment toxicity in an adolescent with T-lymphoblastic lymphoma
20 November 2024, 5:30 PM – 6:30 PM (CET)
Speaker: Fiona Poyer (Austria)
Expert: Marta Pillon (Italy)